Revolution Medicines, Inc. RVMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -242.1%-88.2pp | -202.1%-48.7pp | -173.4%-14.6pp | -159.8%-4.5pp | -153.9%+2.1pp | |
| Return on assets | -191.6%-55.7pp | -164.9%-29.1pp | -144.8%-4.6pp | -138.2%-2.7pp | -135.9%-1.8pp | |
| Return on invested capital | -290.8%-75.2pp | -247.5%-26.1pp | -219.9%+10.7pp | -216.1%+15.5pp | -215.5%+17.4pp | |
| Liquidity | ||||||
| Current ratio | 33.8×-23.5× | 40.4×-21.9× | 47.5×-13.7× | 53.7×-2.9× | 57.3×+4.4× | |
| Quick ratio | 33.8×-23.5× | 40.4×-21.9× | 47.5×-13.7× | 53.7×-2.9× | 57.3×+4.4× | |
| Cash ratio | 5.9×-3.9× | 6.5×-4.3× | 8.5×-3.9× | 9.4×-5.3× | 9.8×-7.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.1× | 0.3×+0.1× | 0.3×+0.1× | 0.3×0.0× | 0.2×0.0× | |
| Debt-to-assets | 0.3×+0.1× | 0.2×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Interest coverage | -1,206.4×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $34.48-21.2% | $37.96-12.1% | $42.88-6.4% | $43.83-0.6% | $43.74+1.7% | |
| Valuation | ||||||
| Market capitalization | $50.86B+77.6% | $38.16B+39.4% | $30.84B+32.2% | $29.68B+57.9% | $28.63B+87.1% | |
| Enterprise value | $50.02B+80.4% | $37.41B+41.4% | $29.91B+34.6% | $28.69B+63.9% | $27.72B+99.7% | |
| Price / book | 31.8×+16.2× | 22.1×+6.6× | 16.2×+2.1× | 15.6×+2.7× | 15.5×+3.5× | |
| Free cash flow yield | -29.8%+1.8pp | -33.4%-2.3pp | -34.5%-1.6pp | -32.9%+2.7pp | -31.6%+4.5pp | |
| Earnings yield | -36.4%-2.7pp | -39.9%-7.7pp | -39.9%-4.4pp | -36.4%+2.5pp | -33.6%+7.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.